MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
16.21
-0.14 (-0.86%)
Aug 18, 2026, 12:24 PM EDT - Market open
MLTX Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, MLTX stock has a consensus rating of "Buy" and an average price target of $28.54. The average 1-year stock price forecast is 76.06% higher than the current stock price, while the lowest is $6.00 (-62.99%) and the highest is $50 (+208.45%).
Price Target: $28.54 (+76.06%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for MLTX stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 10 | 10 | 10 | 10 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Total | 16 | 16 | 15 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $45 → $50 | Buy | Maintains | $45 → $50 | +208.45% | Aug 13, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Reiterates $40 | Buy | Reiterates | $40 | +146.76% | Aug 11, 2026 |
| BTIG | BTIG | Buy Maintains $30 | Buy | Maintains | $30 | +85.07% | Aug 11, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 11, 2026 |
| Needham | Needham | Buy Maintains $30 | Buy | Maintains | $30 | +85.07% | Aug 10, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
19.04M
EPS This Year
-3.33
from -3.53
EPS Next Year
-3.34
from -3.33
EPS and Forward PE are based on non-GAAP adjusted numbers.